241 related articles for article (PubMed ID: 15560649)
1. Drug diverting patients & prescription monitoring--both sides of the debate.
Freeman J
Iowa Med; 2004; 94(5):10-1. PubMed ID: 15560649
[No Abstract] [Full Text] [Related]
2. PADS approach to preventing prescription drug diversion.
Ambre JJ
NIDA Res Monogr; 1993; 131():141-4. PubMed ID: 8413524
[No Abstract] [Full Text] [Related]
3. Prescription drug monitoring programs.
Harrison B
NCSL Legisbrief; 2006 Jan; 14(4):1-2. PubMed ID: 16465702
[No Abstract] [Full Text] [Related]
4. Diversion investigation units--methods, utilities, and limitations.
Bulla RK
NIDA Res Monogr; 1993; 131():145-50. PubMed ID: 8413525
[No Abstract] [Full Text] [Related]
5. Drug diversion control systems, medical practice, and patient care.
Haislip GR
NIDA Res Monogr; 1993; 131():120-31. PubMed ID: 8413522
[No Abstract] [Full Text] [Related]
6. Iowa's prescription drug monitoring program.
Stephenson LL
Iowa Med; 2013; 103(2):14-5. PubMed ID: 25219183
[No Abstract] [Full Text] [Related]
7. Summary and conclusions of a review of prescription drug diversion control methods.
Horgan C; Prottas J; Tompkins C; Wastila L; Bowden M
NIDA Res Monogr; 1993; 131():206-23. PubMed ID: 8413532
[No Abstract] [Full Text] [Related]
8. Programs for monitoring inappropriate prescribing of controlled drugs: evaluation and recommendations.
Collins TM; Zimmerman DR
Am J Hosp Pharm; 1992 Jul; 49(7):1765-8. PubMed ID: 1621738
[No Abstract] [Full Text] [Related]
9. Corneal abrasions and controlled substances.
Brockman TA
J Okla State Med Assoc; 2014 Jul; 107(7):374-5. PubMed ID: 25223150
[No Abstract] [Full Text] [Related]
10. The Medicaid Prescription Drug Initiative.
Roslewicz TD
NIDA Res Monogr; 1993; 131():200-5. PubMed ID: 8413531
[No Abstract] [Full Text] [Related]
11. Triplicate prescription: issues and answers. Introduction.
Farnsworth PB
N Y State J Med; 1991 Nov; 91(11 Suppl):1S-4S. PubMed ID: 1771052
[No Abstract] [Full Text] [Related]
12. An American Medical Association perspective on preventing prescription drug diversion.
Ambre JJ
NIDA Res Monogr; 1993; 131():224-7. PubMed ID: 8413533
[No Abstract] [Full Text] [Related]
13. Myth, mystique, and monopoly in the prescription of medicine.
Sutliff LS
Nurse Pract; 1996 Mar; 21(3):153-5. PubMed ID: 8710251
[No Abstract] [Full Text] [Related]
14. The impact of prescription drug control systems on medical practice and patient care: a summary of the NIDA technical review.
NIDA Res Monogr; 1993; 131():1-17. PubMed ID: 8413519
[No Abstract] [Full Text] [Related]
15. Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem.
Teufel AT
J Contemp Health Law Policy; 2006; 22(2):383-408. PubMed ID: 17117702
[No Abstract] [Full Text] [Related]
16. Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations.
Weintraub M; Singh S; Byrne L; Maharaj K; Guttmacher L
NIDA Res Monogr; 1993; 131():279-93. PubMed ID: 8105386
[No Abstract] [Full Text] [Related]
17. On the regulatory radar screen! Prescriptions for family and for management of pain.
Freeman J
Iowa Med; 2007; 97(6):10. PubMed ID: 18236839
[No Abstract] [Full Text] [Related]
18. Prescription for passing inspection.
Rossi MS
N Y State Dent J; 2007; 73(4):6-7. PubMed ID: 17891874
[No Abstract] [Full Text] [Related]
19. Health authorities and drug utilization studies.
Garcia Alonso F; Scott AI; Stika L; Westerholm B
WHO Reg Publ Eur Ser; 1993; 45():147-67. PubMed ID: 8442843
[No Abstract] [Full Text] [Related]
20. The Drug Enforcement Agency and DEA Form 104.
Stratton WT
Kans Med; 1994 Oct; 95(10):212, 214. PubMed ID: 7815771
[No Abstract] [Full Text] [Related]
[Next] [New Search]
